Stockscreener 앱 받기
50.36
0.45%
-0.23
시간 외 거래:
50.69
0.33
+0.66%
전일 마감가:
$50.59
열려 있는:
$49.345
하루 거래량:
2.16M
Relative Volume:
1.94
시가총액:
$4.29B
수익:
$170.10M
순이익/손실:
$-153.61M
주가수익비율:
-11.27
EPS:
-4.47
순현금흐름:
$-272.35M
1주 성능:
+2.90%
1개월 성능:
+11.00%
6개월 성능:
-9.89%
1년 성능:
-1.24%
1일 변동 폭
$47.04
$50.42
1주일 범위
$46.30
$51.90
52주 변동 폭
$43.42
$91.10
크리스퍼 테라퓨틱스 Stock (CRSP) Company Profile
명칭
Crispr Therapeutics Ag
전화
(617) 315-4600
주소
BAARERSTRASSE 14, ZUG
크리스퍼 테라퓨틱스 Stock (CRSP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-02-15 | 개시 | Wolfe Research | Peer Perform |
| 2023-12-11 | 다운그레이드 | TD Cowen | Market Perform → Underperform |
| 2023-10-17 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2023-09-27 | 개시 | Mizuho | Buy |
| 2023-08-17 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-05-30 | 개시 | William Blair | Outperform |
| 2023-04-13 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-03-21 | 개시 | Bernstein | Mkt Perform |
| 2023-03-17 | 개시 | Bryan Garnier | Buy |
| 2023-03-07 | 개시 | Robert W. Baird | Neutral |
| 2022-10-11 | 개시 | Morgan Stanley | Underweight |
| 2022-08-09 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2022-06-23 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-06-17 | 개시 | BMO Capital Markets | Outperform |
| 2022-04-28 | 개시 | Credit Suisse | Neutral |
| 2021-12-07 | 개시 | Cowen | Market Perform |
| 2021-10-19 | 개시 | SVB Leerink | Outperform |
| 2021-06-14 | 업그레이드 | Citigroup | Sell → Neutral |
| 2021-04-21 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-03-04 | 개시 | JMP Securities | Mkt Outperform |
| 2020-12-10 | 재확인 | Chardan Capital Markets | Buy |
| 2020-12-10 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-12-10 | 재확인 | Needham | Buy |
| 2020-12-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-10-23 | 개시 | RBC Capital Mkts | Sector Perform |
| 2020-10-05 | 개시 | BofA Securities | Buy |
| 2020-07-28 | 재확인 | Needham | Buy |
| 2020-07-14 | 개시 | SunTrust | Buy |
| 2020-06-15 | 재확인 | Canaccord Genuity | Buy |
| 2020-03-05 | 개시 | Stifel | Hold |
| 2020-02-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-11-19 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2019-11-12 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2019-08-01 | 개시 | Jefferies | Buy |
| 2019-07-26 | 개시 | Canaccord Genuity | Buy |
| 2019-06-10 | 개시 | ROTH Capital | Buy |
| 2019-04-12 | 개시 | Evercore ISI | Outperform |
| 2019-03-14 | 개시 | William Blair | Mkt Perform |
| 2019-01-28 | 다운그레이드 | Goldman | Buy → Neutral |
| 2019-01-22 | 다운그레이드 | Citigroup | Neutral → Sell |
모두보기
크리스퍼 테라퓨틱스 주식(CRSP)의 최신 뉴스
Leerink cuts CRISPR Therapeutics target to $67, keeps Outperform - Investing.com
CRISPR Therapeutics (CRSP) PT Lowered to $67 at Leerink Partners - StreetInsider.com
CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 4%Here's Why - MarketBeat
CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Lags Revenue Estimates - MSN
CRSPCRISPR Therapeutics AG Latest Stock News & Market Updates - StockTitan
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results - GlobeNewswire
CRISPR Therapeutics AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
CRISPR Therapeutics AG (CRSP) Just Overtook the 20-Day Moving Average - Zacks Investment Research
CRISPR Therapeutics AG (CRSP) Recently Broke Out Above the 50-Day Moving Average - Yahoo Finance
International Assets Investment Management LLC Invests $1.83 Million in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Acquired by Capital Advisors Inc. OK - MarketBeat
CRISPR Therapeutics (NASDAQ:CRSP) Trading Up 7.2%Still a Buy? - MarketBeat
Is CRISPR Therapeutics (CRSP) a Promising Gene Editing Stock? - MSN
Crispr Therapeutics: Avoid Catching The Falling Knife This Time (Downgrade) (NASDAQ:CRSP) - Seeking Alpha
CRISPR Therapeutics to Report Q3 Earnings: Is a Beat in Store? - MSN
CRISPR Therapeutics (NASDAQ:CRSP) Raised to "Sell" at StockNews.com - MarketBeat
Shareholders in CRISPR Therapeutics (NASDAQ:CRSP) are in the red if they invested three years ago - Simply Wall St
Crispr Therapeutics: Poised For A Major Turnaround (NASDAQ:CRSP) - Seeking Alpha
This Healthcare Growth Stock Could Be a Steal of a Deal Right Now - MSN
The Ultimate Biotech Stock to Buy With $50 Right Now - MSN
CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note - MSN
CRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to Know - MSN
Wall Street Analysts See a 67.54% Upside in CRISPR Therapeutics (CRSP): Can the Stock Really Move This High? - MSN
How the (CRSP) price action is used to our Advantage - Stock Traders Daily
CRISPR Therapeutics AG (CRSP) Advances While Market Declines: Some Information for Investors - MSN
We Think CRISPR Therapeutics (NASDAQ:CRSP) Can Easily Afford To Drive Business Growth - Yahoo Finance
3 Bargain Stocks to Buy in a Market That's Priced for Perfection - The Motley Fool
Is CRISPR Therapeutics AG (CRSP) the Most Promising Biotech Stock According to Hedge Funds? - Insider Monkey
Crispr therapeutics CEO sells shares worth $198,680 By Investing.com - Investing.com Australia
Crispr Therapeutics' general counsel sells $50,398 in shares By Investing.com - Investing.com Australia
Crispr Therapeutics' general counsel sells $50,398 in shares - Investing.com India
CRISPR Therapeutics AG (NASDAQ:CRSP) General Counsel Sells $50,398.92 in Stock - MarketBeat
Crispr therapeutics CEO sells shares worth $198,680 - Investing.com
CRISPR Therapeutics (NASDAQ:CRSP) Trading Down 0.9%Here's Why - MarketBeat
CRISPR Therapeutics (NASDAQ:CRSP) Trading Down 1.2%Here's Why - MarketBeat
CRISPR Therapeutics AG (NASDAQ:CRSP) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Gene Editing Technology Market Is in Huge Demand:Thermo Fisher Scientific, SIGMA ALDRICH, Dharmacon, Cellectics, CRISPR Therapeutics, A – IndiaPolitics.com - IndiaPolitics.com
Is CRISPR Therapeutics Stock a Buy? - Yahoo Finance
2 Biotech Stocks That Are Screaming Buys This Month - Yahoo Finance
Handelsbanken Fonder AB Lowers Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
CRISPR Therapeutics (NASDAQ:CRSP) Shares Up 0.6%Time to Buy? - MarketBeat
Page 6 | CRISPR Therapeutics AG Trade Ideas — CAPITALCOM:CRSP - TradingView
Page 4 | CRISPR Therapeutics AG Trade Ideas — CAPITALCOM:CRSP - TradingView
CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 0.5%Time to Sell? - MarketBeat
CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: Here's Why - MSN
Gene Editing Tools Market Poised for Massive Growth (2024-2031) - openPR
(CRSP) Trading Signals - Stock Traders Daily
크리스퍼 테라퓨틱스 (CRSP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.02%
0.47%
자본화:
|
볼륨(24시간):